drugset / Trial / NCT06218797

Nebulized Dexmedetomidine as a Premedication for Gastrointestinal Endoscopy in Pediatric Patients

NCT06218797 ↗

Completed 108 enrolled Ondokuz Mayıs University
RandomizedParallel-groupTriple-blindSupportive care

Summary

This study aims to demonstrate that the application of nebulized dexmedetomidine to patients during pediatric upper gastrointestinal endoscopic procedures will significantly reduce the gag reflex and enhance both patient and practitioner comfort

Timeline

Start
2024-01-31
Primary completion
2024-04-30
Completion
2024-08-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 2 ug/kg Other

Indications

No indication recorded.